Ramiro Guerrero - 24 Feb 2025 Form 4/A - Amendment Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Ramiro Guerrero
Issuer symbol
MAIA
Transactions as of
24 Feb 2025
Net transactions value
+$247,132
Form type
4/A - Amendment
Filing time
05 Mar 2025, 16:37:22 UTC
Date Of Original Report
25 Feb 2025
Previous filing
03 Jan 2025
Next filing
05 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $110,000 +73,333 +16% $1.50 534,885 24 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Warrants Purchase $137,133 +73,333 $1.87 73,333 24 Feb 2025 Common Stock 73,333 $1.87 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plna on February 24, 2025.
F2 This Form 4/A is being filed to correct the "Date Exercisable" and "Expiration Date" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 2 to "February 24, 2025".
F3 These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.